AF
AVEO

Advisornet Financial’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Advisornet Financial’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-100
Closed -$1.5K – 2512
2022
Q4 		$1.5K Hold
100
– – ﹤0.01% 1728
2022
Q3 		$1K Hold
100
– – ﹤0.01% 1842
2022
Q2 		$1K Hold
100
– – ﹤0.01% 1855
2022
Q1 		$1K Hold
100
– – ﹤0.01% 1974
2021
Q4 		$0 Hold
100
– – ﹤0.01% 2206
2021
Q3 		$1K Hold
100
– – ﹤0.01% 1863
2021
Q2 		$1K Hold
100
– – ﹤0.01% 1792
2021
Q1 		$1K Hold
100
– – ﹤0.01% 1740
2020
Q4 		$1K Hold
100
– – ﹤0.01% 1644
2020
Q3 		$1K Hold
100
– – ﹤0.01% 1707
2020
Q2 		$1K Hold
100
– – ﹤0.01% 1748
2020
Q1 		$0 Sell
100
-300
-75% -$1.49K ﹤0.01% 2023
2019
Q4 		$2K Hold
400
– – ﹤0.01% 1717
2019
Q3 		$3K Hold
400
– – ﹤0.01% 1657
2019
Q2 		$3K Hold
400
– – ﹤0.01% 1497
2019
Q1 		$3K Buy
400
+100
+33% +$1.03K ﹤0.01% 1400
2018
Q4 		$5K Buy
+300
New +$6.6K ﹤0.01% 1255

Advisornet Financial's AVEO Position: Q1 2023 in Review

Advisornet Financial sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 100 shares — an estimated $1.5K sold.

Advisornet Financial first reported a position in AVEO in Q4 2018 and held it in 17 quarters. The position peaked at $5K in Q4 2018. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • Advisornet Financial reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Advisornet Financial sold 100 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $1.5K.
  • Advisornet Financial first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2018 and held it in 17 quarters.
  • Advisornet Financial's AVEO Pharmaceuticals, Inc. position peaked at $5K in Q4 2018.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Advisornet Financial's 13F filing for Q1 2023, filed 28 Apr 2023.